American Society of Hematology

SHERPA: Blue

People

  1. Giralt
    Giralt
  2. Zelenetz
    Zelenetz
  3. Levine
    Levine
  4. Perales
    Perales
  5. Tallman
    Tallman
  6. O'Reilly
    O'Reilly
  7. Horwitz
    Horwitz
  8. Devlin
    Devlin
  9. Palomba
    Palomba
  10. Abdel-Wahab
    Abdel-Wahab

Groups

  1. Department of Medicine (4000)
  2. Hematologic Malignancies, Division of (3803)
  3. Center for Hematologic Malignancies (3680)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1343)
  6. Sloan Kettering Institute Faculty (1075)
  7. Bone Marrow Transplant (988)
  8. Center for Molecular Imaging and Biotechnology (CMIB) (955)
  9. Lymphoma (941)
  10. Tow Center for Developmental Oncology (TCDO) (882)
Search Within
Formats
  1. Meeting Abstract (4150)
  2. Journal Article (1257)
  3. Research Letter (46)
  4. Review (44)
  5. Editorial (35)
  6. Guidelines (13)
  7. Correspondence (7)
  8. Miscellaneous (3)
Groups
  1. Department of Medicine (4000)
  2. Hematologic Malignancies, Division of (3803)
  3. Center for Hematologic Malignancies (3680)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1343)
  6. Sloan Kettering Institute Faculty (1075)

More Groups

People
  1. Sergio Giralt (348)
  2. Andrew Zelenetz (341)
  3. Ross Levine (316)
  4. Miguel-Angel Perales (312)
  5. Martin Tallman (301)
  6. Richard O'Reilly (281)

More People

Years
  1. 2025 (64)
  2. 2024 (428)
  3. 2023 (478)
  4. 2022 (369)
  5. 2021 (284)
  6. 2020 (261)

More Years

Publications
  1. Blood (5174)
  2. Blood Advances (331)
  3. Hematology-American Society of Hematology Education Program (50)

Results (5555)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Intensive induction chemotherapy (IC) vs hypomethylating agents plus venetoclax (HMA/VEN) in IDH1-or IDH2-mutant newly diagnosed acute myeloid leukemia (AML) - A multicenter cohort study
    Meeting Abstract

    Bewersdorf, J. P.; Shimony, S.; Shallis, R. M.; Liu, Y.; Schaefer, E. J.; Zeidan, A. M.; Goldberg, A. D.; Stein, E. M.; Marcucci, G.; Lindsley, R. C.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Genomic evolution and resistance during pirtobrutinib therapy in covalent btk-inhibitor (cBTKi) pre-treated chronic lymphocytic leukemia patients: Updated analysis from the BRUIN study
    Meeting Abstract

    Brown, J. R.; Desikan, S. P.; Nguyen, B.; Won, H.; Tantawy, S. I.; McNeely, S.; Marella, N.; Ebata, K.; Woyach, J. A.; Patel, K.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Trem-cel, a CRISPR/Cas9 gene-edited allograft lacking CD33, shows rapid primary engraftment with CD33-negative hematopoiesis in patients with high-risk acute myeloid leukemia (AML) and avoids hematopoietic toxicity during gemtuzumab ozogamicin (GO) maintenance post-hematopoietic cell transplant (HCT)
    Meeting Abstract

    DiPersio, J.; Cooper, B. W.; Suh, H. C.; Koura, D.; Bernard, L.; Shah, N. N.; Walter, R. B.; Perales, M. A.; Mapara, M.; Tamari, R.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Response to mosunetuzumab in patients with B-cell lymphomas relapsed or refractory after CAR-T cell therapy is associated with changes in lymphocyte counts
    Meeting Abstract

    Chong, E. A.; Penuel, E.; Bartlett, N. L.; Bosch, F.; Budde, L. E.; Fay, K.; Flinn, I. W.; Goy, A.; Kumar, A.; Lundberg, R.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Loss of CCAAT-enhancer binding protein delta promotes acute myeloid leukemia cell proliferation and survival by upregulating cyclin D1 expression
    Meeting Abstract

    Prajapati, S.; Meydan, C.; Dillon, R.; Dunham, N.; Fan, H.; Gandara, J. A.; Lee, T.; Neelamraju, Y.; Wang, Z.; Zumbo, P.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A phase II multicenter clinical trial assessing the safety and efficacy of ixazomib, pomalidomide and dexamethasone combination as second or third-line treatment for triple-class exposed patients with relapsed and refractory multiple myeloma (iPod-790 Trial)
    Meeting Abstract

    Cohen, Y. C.; Shragai, T.; Lavi, N.; Vaxman, I.; Chubar, E.; Gatt, M. E.; Ganzel, C.; Magen, H.; Luttwak, E.; Mittelman, M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • HMGA1 chromatin regulators drive immune evasion in MPN progression through epigenetic rewiring to repress antigen presentation
    Meeting Abstract

    Kim, J.; Supreme, A. A.; West, B.; Antopia, M. C.; Reddy, K.; Cope, L.; Kim, J. H.; Rampal, R. K.; Koche, R.; Spivak, J. L.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Aplastic anemia patients have diverse T cell repertoires and flexible T cell responses similar to healthy individuals
    Meeting Abstract

    Hu, A. C.; Kumar, S.; Enache, A. B. S.; Dulmovits, B. M.; Shah, Y. B.; Meng, W. Z.; Oved, J. H.; Carreno, B. M.; Prak, E. T. L.; Olson, T. S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Novel causal inference method estimates treatment effects of contemporary drugs in a global cohort of patients with relapsed and refractory mature T-cell and NK-cell neoplasms
    Meeting Abstract

    Koh, M. J.; Boussi, L.; Han, J. X.; Peng, L.; Sorial, M. N.; Eche-Ugwu, I. J.; Miranda, E.; Chiattone, C.; Stuver, R.; Horwitz, S. M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Comparative effectiveness of axicabtagene ciloleucel vs historical standard-of-care in patients with relapsed or refractory follicular lymphoma: An analysis of CIBMTR and SCHOLAR-5 data
    Meeting Abstract

    Kambhampati, S.; Wang, H. L.; Yan, J.; Herrera, A. F.; Frank, M. J.; Popplewell, L. L.; Ahmed, N.; Lin, Y.; Locke, F. L.; Ghione, P.; more...
    Blood (2023)

    Fulltext@MSK | Save